Financials
- Market Capitalization 9.35 B
- Employee 273
- Founded 2015
- CEO N/A
- Website www.kymeratx.com
- Headquarter Delaware, United States
- FIGI BBG00SDHC8D1
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-21.09
市销率
167.66
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 890 | KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 79.78 USD | +1.31% | +5.02% | +2.43% | +101.24% | 10.15 B USD | ||
| 907 | KRYS Krystal Biotech, Inc. - Common Stock | 331.61 USD | +1.32% | +2.42% | -5.46% | +77.21% | 9.82 B USD | ||
| 933 | PTGX Protagonist Therapeutics, Inc. - Common Stock | 143.73 USD | +2.73% | +2.04% | -4.13% | +91.31% | 9.30 B USD | ||
| 961 | ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 62.75 USD | +3.31% | -3.10% | -24.13% | +60.49% | 8.86 B USD |